Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.

Magnani A, Pondarré C, Bouazza N, Magalon J, Miccio A, Six E, Roudaut C, Arnaud C, Kamdem A, Touzot F, Gabrion A, Magrin E, Couzin C, Fusaro M, André I, Vernant JP, Gluckman E, Bernaudin F, Bories D, Cavazzana M.

Haematologica. 2019 Sep 19. pii: haematol.2019.227561. doi: 10.3324/haematol.2019.227561. [Epub ahead of print]

2.

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Bernaudin F, Dalle JH, Bories D, Peffault de Latour R, Robin M, Bertrand Y, Pondarre C, Vannier JP, Neven B, Kuentz M, Maury S, Lutz P, Paillard C, Yakouben K, Thuret I, Galambrun C, Dhedin N, Jubert C, Rohrlich P, Bay JO, Suarez F, Raus N, Vernant JP, Gluckman E, Poirot C, Socié G; Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Haematologica. 2019 May 16. pii: haematol.2018.213207. doi: 10.3324/haematol.2018.213207. [Epub ahead of print]

3.

Acute mast cell leukemia: A rare but highly aggressive hematopoietic neoplasm.

Costopoulos M, Uzunov M, Bories D, Charlotte F, Maloum K, Arock M.

Diagn Cytopathol. 2018 Jul;46(7):639-641. doi: 10.1002/dc.23965. Epub 2018 May 7. No abstract available.

PMID:
29736992
4.

Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.

Algrin C, Golmard JL, Michallet M, Reman O, Huynh A, Perrot A, Sirvent A, Plesa A, Salaun V, Béné MC, Bories D, Tournilhac O, Merle-Béral H, Leblond V, Le Garff-Tavernier M, Dhedin N.

Eur J Haematol. 2017 Apr;98(4):363-370. doi: 10.1111/ejh.12836. Epub 2017 Jan 30.

PMID:
27943415
5.

Face transplant: long-term follow-up and results of a prospective open study.

Lantieri L, Grimbert P, Ortonne N, Suberbielle C, Bories D, Gil-Vernet S, Lemogne C, Bellivier F, Lefaucheur JP, Schaffer N, Martin F, Meningaud JP, Wolkenstein P, Hivelin M.

Lancet. 2016 Oct 1;388(10052):1398-1407. doi: 10.1016/S0140-6736(16)31138-2. Epub 2016 Aug 25.

PMID:
27567680
6.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, Moatti H, Flandrin P, Marzac C, Bories D, Fava F, Mokrani H, Betems A, Lorre F, Favier R, Féger F, Mohty M, Douay L, Legrand O, Bilhou-Nabera C, Louache F, Delhommeau F.

Nat Commun. 2016 Aug 18;7:12475. doi: 10.1038/ncomms12475.

7.

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Hirsch P, Mamez AC, Belhocine R, Lapusan S, Tang R, Suner L, Bories D, Marzac C, Fava F, Legrand O, Mohty M, Douay L, Delhommeau F.

Leukemia. 2016 Aug;30(8):1756-9. doi: 10.1038/leu.2016.31. Epub 2016 Mar 1. No abstract available.

PMID:
26876594
8.

Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Jacque N, Nguyen S, Golmard JL, Uzunov M, Garnier A, Leblond V, Vernant JP, Bories D, Dhédin N.

Bone Marrow Transplant. 2015 Feb;50(2):259-65. doi: 10.1038/bmt.2014.254. Epub 2014 Nov 10.

PMID:
25387089
9.

[Chronic myeloid leukemia and imatinib: Experience at the Lome Campus teaching hospital (Togo)].

Segbena AY, Kueviakoe IM, Agbetiafa K, Padaro E, Layibo Y, Dorkenoo A, Agbo YM, Bories D.

Med Sante Trop. 2012 Jul-Sep;22(3):307-11. doi: 10.1684/mst.2012.0083. French.

10.

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?

Redjoul R, Toma A, Hicheri Y, El Maaroufi H, Maertens J, Vigouroux S, Lioure B, Machaczka M, Pautas C, Bories D, Wagner-Ballon O, Gaulard P, Martin-Garcia N, Maury S, Cordonnier C.

Eur J Haematol. 2012 May;88(5):458-60. doi: 10.1111/j.1600-0609.2012.01757.x. Epub 2012 Feb 14. No abstract available.

PMID:
22268532
11.

Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.

Malfuson JV, Konopacki J, Fagot T, Desangles F, Bories D, Souleau B, de Revel T.

Ann Hematol. 2011 Dec;90(12):1477-9. doi: 10.1007/s00277-011-1188-1. Epub 2011 Feb 25. No abstract available.

PMID:
21350831
12.

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.

Nguyen S, Béziat V, Norol F, Uzunov M, Trebeden-Negre H, Azar N, Boudifa A, Bories D, Debré P, Vernant JP, Vieillard V, Dhédin N.

Transfusion. 2011 Aug;51(8):1769-78. doi: 10.1111/j.1537-2995.2010.03058.x. Epub 2011 Feb 18.

PMID:
21332732
13.

CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.

Maury S, Lemoine FM, Hicheri Y, Rosenzwajg M, Badoual C, Cheraï M, Beaumont JL, Azar N, Dhedin N, Sirvent A, Buzyn A, Rubio MT, Vigouroux S, Montagne O, Bories D, Roudot-Thoraval F, Vernant JP, Cordonnier C, Klatzmann D, Cohen JL.

Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.

14.

Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.

Roos-Weil D, Nguyen S, Uzunov M, Bories D, Chapiro E, Nguyen-Khac F, Vernant JP, Dhédin N.

Bone Marrow Transplant. 2010 Sep;45(9):1471-3. doi: 10.1038/bmt.2009.369. Epub 2010 Jan 25. No abstract available.

PMID:
20098458
15.

Fully functional NK cells after unrelated cord blood transplantation.

Beziat V, Nguyen S, Lapusan S, Hervier B, Dhedin N, Bories D, Uzunov M, Boudifa A, Trebeden-Negre H, Norol F, Marjanovic Z, Marie JP, Vernant JP, Debre P, Rio B, Vieillard V.

Leukemia. 2009 Apr;23(4):721-8. doi: 10.1038/leu.2008.343. Epub 2009 Jan 8.

PMID:
19151772
16.

Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation.

Nguyen S, Kuentz M, Vernant JP, Dhedin N, Bories D, Debré P, Vieillard V.

Leukemia. 2008 Feb;22(2):344-52. Epub 2007 Nov 22.

PMID:
18033316
18.

Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation.

Nicolini FE, Hayette S, Corm S, Bachy E, Bories D, Tulliez M, Guilhot F, Legros L, Maloisel F, Kiladjian JJ, Mahon FX, Lê QH, Michallet M, Roche-Lestienne C, Preudhomme C.

Haematologica. 2007 Sep;92(9):1238-41.

19.

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.

Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, Vannier JP, Yakouben K, Thuret I, Bordigoni P, Fischer A, Lutz P, Stephan JL, Dhedin N, Plouvier E, Margueritte G, Bories D, Verlhac S, Esperou H, Coic L, Vernant JP, Gluckman E; SFGM-TC.

Blood. 2007 Oct 1;110(7):2749-56. Epub 2007 Jul 2.

PMID:
17606762
20.

Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation.

Fouillard L, Chapel A, Bories D, Bouchet S, Costa JM, Rouard H, Hervé P, Gourmelon P, Thierry D, Lopez M, Gorin NC.

Leukemia. 2007 Mar;21(3):568-70. Epub 2007 Jan 25. No abstract available.

PMID:
17252011
21.

PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.

Karlin L, Itti E, Pautas C, Rachid M, Bories D, Cordonnier C, Maury S.

Haematologica. 2006 Dec;91(12 Suppl):ECR54. No abstract available.

22.

Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult B-lineage ALL patients: the LALA 94 experience.

Picard C, Hayette S, Bilhou-Nabera C, Cayuela JM, Delabesse E, Frenoy N, Preudhomme C, Dupont M, Bastard C, Bories D, Vaerman JL, Davi F, Dastugue N, Raynaud S, Lafage M, Deschaseaux F, Fest T, Gaub MP, Lhéritier V, Thomas X, Charrin C, Boucheix C, Dombret H, Macintyre E, Fière D, Gabert J.

Leukemia. 2006 Dec;20(12):2178-81. Epub 2006 Oct 12. No abstract available.

PMID:
17039237
23.

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.

Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela JM, Dombret H, Dastugue N, Huguet F, Bastard C, Stamatoulas A, Giollant M, Tournilhac O, Macintyre E, Buzyn A, Bories D, Kuentz M, Dreyfus F, Delannoy A, Raynaud S, Gratecos N, Bordessoule D, de Botton S, Preudhomme C, Reman O, Troussard X, Pigneux A, Bilhou C, Vernant JP, Boucheix C, Gabert J; GET-LALA Group the Swiss Group for Clinical Cancer Research (SAKK).

Leukemia. 2006 Dec;20(12):2155-61. Epub 2006 Oct 12.

PMID:
17039234
24.

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(phi)-LMC GROUP).

Nicolini FE, Corm S, Lê QH, Sorel N, Hayette S, Bories D, Leguay T, Roy L, Giraudier S, Tulliez M, Facon T, Mahon FX, Cayuela JM, Rousselot P, Michallet M, Preudhomme C, Guilhot F, Roche-Lestienne C.

Leukemia. 2006 Jun;20(6):1061-6.

PMID:
16642048
25.

Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.

Ossard-Receveur A, Bernheim A, Clausse B, Danglot G, Fauvet D, Leon B, Lozach F, Bories D, Brouzes C, Bourhis JH, Turhan AG.

Cancer Genet Cytogenet. 2005 Dec;163(2):189-90. No abstract available.

PMID:
16337868
26.
27.

Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma.

Fouillard L, Bensidhoum M, Bories D, Bonte H, Lopez M, Moseley AM, Smith A, Lesage S, Beaujean F, Thierry D, Gourmelon P, Najman A, Gorin NC.

Leukemia. 2003 Feb;17(2):474-6. No abstract available.

PMID:
12592355
28.

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction.

Alizadeh M, Bernard M, Danic B, Dauriac C, Birebent B, Lapart C, Lamy T, Le Prisé PY, Beauplet A, Bories D, Semana G, Quelvennec E.

Blood. 2002 Jun 15;99(12):4618-25.

PMID:
12036896
29.

Molecular analysis of an unusual rearrangement between chromosomes 4 and 11 in adult pre-B-cell acute lymphoblastic leukemia.

Chami I, Pérot C, Portnoï MF, Jouault H, Rieux C, Pautas C, Kuentz M, Tulliez M, Bories D.

Cancer Genet Cytogenet. 2002 Mar;133(2):129-33.

PMID:
11943339
30.
31.

Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after allogeneic stem cell transplantation.

Maury S, Jouault H, Kuentz M, Vernant JP, Tulliez M, Cordonnier C, Bories D.

Transplantation. 2001 Feb 15;71(3):374-80.

PMID:
11233896
32.

Methylenetetrahydrofolate reductase deficiency in four siblings: a clinical, biochemical, and molecular study of the family.

Tonetti C, Burtscher A, Bories D, Tulliez M, Zittoun J.

Am J Med Genet. 2000 Apr 24;91(5):363-7.

PMID:
10767000
33.
34.

Apparent reactivation of a red cell alloantibody in a healthy individual after G-CSF administration.

Norol F, Bonin P, Charpentier F, Bierling P, Beaujean F, Cartron JP, Bories D, Kuentz M.

Br J Haematol. 1998 Oct;103(1):256-8.

PMID:
9792318
35.

The first pathogenic mitochondrial methionine tRNA point mutation is discovered in splenic lymphoma.

Lombès A, Bories D, Girodon E, Frachon P, Ngo MM, Breton-Gorius J, Tulliez M, Goossens M.

Hum Mutat. 1998;Suppl 1:S175-83.

PMID:
9452079
36.

TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.

Raynaud S, Mauvieux L, Cayuela JM, Bastard C, Bilhou-Nabera C, Debuire B, Bories D, Boucheix C, Charrin C, Fière D, Gabert J.

Leukemia. 1996 Sep;10(9):1529-30. No abstract available.

PMID:
8751475
37.

Structure and expression of the human GATA3 gene.

Labastie MC, Bories D, Chabret C, Grégoire JM, Chrétien S, Roméo PH.

Genomics. 1994 May 1;21(1):1-6.

PMID:
8088776
38.

Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains.

Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, Yamamoto M, Engel JD.

Mol Cell Biol. 1994 Mar;14(3):2201-12.

39.

A T-cell specific TCR delta DNA binding protein is a member of the human GATA family.

Joulin V, Bories D, Eléouet JF, Labastie MC, Chrétien S, Mattéi MG, Roméo PH.

EMBO J. 1991 Jul;10(7):1809-16.

40.

Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells.

Bories D, Raynal MC, Solomon DH, Darzynkiewicz Z, Cayre YE.

Cell. 1989 Dec 22;59(6):959-68.

PMID:
2598267
41.

Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells.

Pérignon JL, Bories DM, Houllier AM, Thuillier L, Cartier PH.

Biochim Biophys Acta. 1987 Apr 22;928(2):130-6.

PMID:
3567226
42.

[Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].

Girot R, Triadou P, Bories D, Jeannel F, Thevenin M, Rymer JC.

Nouv Rev Fr Hematol. 1982;24(5):281-7. French.

PMID:
7167380

Supplemental Content

Loading ...
Support Center